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Abstract
Non-invasive forearm ischemia-reperfusion injury and low flow induced vascular dysfunction models provide methods to
evaluate vascular function. The role of oestrogen, an endogenous anti-oxidant on recovery from ischemia-reperfusion injury
has not been evaluated nor has the impact of prolonged low flow on vascular function been established. Eight healthy
women (33610 yr) attended the lab during the follicular, ovulatory and mid-luteal phases of their menstrual cycles. After 30
minutes of rest, brachial artery vascular function was assessed by ultrasound measurements of diameter changes during 5
minutes of forearm ischemia and 3 minutes after. Subsequently, a 20-minute forearm ischemia period was completed.
Further, vascular function assessments were completed 15, 30 and 45 minutes into recovery. Flow-mediated dilation, low-
flow-mediated constriction, and reactive hyperaemia proximal to the area of ischemia were determined. Flow-mediated
dilation was reduced at 15 minutes of recovery but recovered at 30 and 45 minutes (PRE: 7.161.0%, POST15:4.560.6%,
POST30:5. 560.7% POST45:5.960.4%, p,0.01). Conversely, low-flow mediated constriction increased (PRE: 21.360.4%,
POST15: 23.360.6%, POST30: 22.560.5% POST45: 21.560.12%, p,0.01). Reactive hyperaemia was reduced throughout
recovery (p,0.05). Data were unaffected by menstrual phase. Prolonged low flow altered vascular function and may relate
as much to increased vasoconstriction as with decreased vasodilation. Reductions in anterograde shear and greater
retrograde shear likely modulate the brachial artery response, but the reduced total shear also plays an important role. The
data suggest substantial alterations in vascular function proximal to areas of ischemia with potential clinical implications
following reperfusion.
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Introduction
The forearm ischemia-reperfusion (I/R) model has been used to
create an induced arterial vascular endothelial injury in several
recent studies and has provided insightful information about
potential interventions to attenuate the associated dysfunction or
prevent the injury [1–5]. Specifically, the associated dysfunction
may be attenuated by intra-arterial vitamin C infusion [1] whereas
remote or distant prior ischemia [2,4] and sildenafil [6] are
thought to attenuate the magnitude of the injury. Each of these
treatments impacts nitric oxide bioavailability through the
scavenging of reactive oxygen species [1], activation of endoge-
nous antioxidant systems [2–4], or through the inhibition of
cGMP degradation by cGMP-specific phosphodiesterase type 5.
The later limits opening of mitochondrial KATP channels that then
lead to apoptosis [5,6].
Blood flow dynamics and shear rates are altered upstream of
a site of ischemia. In models where endothelial cells are located
proximal to an area of ischemia, altered gene expression of these
endothelial cells is apparent and includes reduced expression of
eNOS (endothelial nitric oxide synthase), extracellular and copper-
zinc superoxide dismutases, and prostaglandin I2 synthase, and
increased expression of endothelin-1 and procoagulant factors [7].
However, in vivo prolonged low flow in humans has rarely been
studied and the time course of altered vascular function following
low flow interventions is unknown.
In studies addressing prolonged low flow using venous
congestion, distal cuff inflation, or I/R induced endothelial
alterations, repeated flow-mediated dilation (FMD) protocols are
used to measure vascular endothelial function [2,3,6,8]. The
procedure involves forearm occlusion for a 5-minute period and
subsequent measurement of the dilation of the artery under
observation. These manipulations involve an initial measurement
of FMD prior to the intervention (at least 10 minutes prior), a 20-
minute upper or lower arm occlusion period, and subsequent
FMD protocols throughout recovery. As described, many inter-
ventions improve recovery from these manipulations [2–6,9].
Specifically, exercise training in sedentary middle–aged partici-
pants attenuated endothelial dysfunction induced by distal
occlusion [8]. Devan et al. (2011) suggest this relates to enhanced
NO bioavailability, reduced oxidative stress and inflammation.
In females, endogenous 17-b estradiol may also confer pro-
tection against prolonged low flow (PLF) or I/R injury via
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enhanced NO bioavailability and scavenging of reactive oxygen
species [10]. Fluctuations of 17-b estradiol and progesterone
throughout the normal menstrual cycle may impact the magnitude
of PLF or I/R injury and the kinetics of recovery. As well, since
reperfusion causes significant tissue damage through calcium
loading, inflammation and a surge of reactive oxygen species
production, it may be that prior exposure to 17-b estradiol would
limit these effects and offer some degree of protection. To address
the hypothesis that endogenous fluctuating hormonal status may
impact recovery of vascular function after prolonged low flow we
evaluated this parameter prior to and following this intervention at
3 points during the normal menstrual cycle.
A second purpose of this study was to comprehensively evaluate
brachial artery vascular function in response to a distal low flow
stimulus. Current guidelines for FMD emphasize measuring both
arterial shear rates and diameters throughout the protocol [11,12]
however; few studies have followed these recommendations when
evaluating I/R or PLF [2,3,6,8] with two studies reporting only
the peak to baseline flow ratio as the stimulus for dilation as
unchanged [2,3]. In addition, complementary information may
also be gathered during comprehensive vascular evaluations
including the magnitude of the vasoconstriction of the brachial
artery during distal arterial occlusion. Specifically, this low-flow
mediated constriction (L-FMC) provides an index of basal
endothelial contribution to vasomotor function [13], which may
be partially mediated by endothelin-1 [14] or through inhibiting
endothelial derived hyperpolaring factor (EDHF) and cycloox-
ygenase products (e.g. prostaglandins) [15]. By measuring L-FMC
and total vascular reactivity, the absolute sum of L-FMC and
FMD, we can determine whether there is truly a reduction in
endothelial vasomotor function or in fact there is an altered
endothelial contribution to basal vasomotor function following
PLF.
Methods
Ethics Statement
The experimental procedures and potential risks were explained
prior to the study when participants attended an initial familiar-
ization session. All participants provided written informed consent
to participate. The Faculty of Biological Sciences Ethics Board at
the University of Leeds approved the experimental protocol,
which conformed to the Declaration of Helsinki.
Participants
Healthy women (n = 8) volunteered for the study (Mean 6 SD,
age: 33610, SBP: 115611, DBP: 7369, HR: 6468). Participants
were: (a) free from apparent cardiovascular, pulmonary or
metabolic disease and not taking medication. Other exclusion
criteria included pregnancy and smoking as assessed through
initial screening. All had self-reported menstrual cycles lasting
between 28 and 32 days and had regular menstrual cycles without
the use of hormonal contraceptive preparations for the previous 6
months.
Study Design and Procedures
Participants were initially asked to provide an estimate of their
regular menstrual cycle length and only those who had reliable
(within 2–3 days) menstrual cycles were included in the study.
Participants reported the first day of their cycle (the onset of
menstrual bleeding) and subsequent testing procedures were
determined from this date. Specifically, early follicular (day 2–4),
ovulation (Day 12–14) and mid-late luteal phase (Day 21–28) were
chosen to cover three instances when oestrogen and progesterone
levels would be altered. As such, day 1 represented the first day of
menstrual blood loss, the follicular phase where both hormone
concentrations were low, ovulation where estrogen concentration
was high and progesterone low, and mid-late luteal where both
hormone concentrations were high. Participants attended the
temperature controlled (22–24uC) laboratory on these three
occasions in sequential order; however, the experimenter was
blinded to this via random initiation of the first visit. Thus, the
experimenters were blind to menstrual cycle phase. Participants
were also instructed to abstain from strenuous exercise for at least
24 hours, and arrived at the laboratory in the morning following
an overnight fast and abstinence from caffeine. This was verbally
confirmed at each session.
Figure 1 illustrates the time-line of each experimental session.
Briefly, participants were initially instrumented in the supine
position after which a 20-minute resting period was completed.
Following this an assessment of arterial vascular function was
conducted on the right brachial artery using the FMD protocol
(i.e. PRE). The arm was maintained in this abducted position
throughout each experimental session. Following 10 minutes of
recovery from the first assessment of vascular function, a 20-
minute forearm occlusion and thus prolonged upstream low flow
was induced via the same cuff as previously outlined by DeVan
et al. (2011), which was maintained at 250–300 mmHg. Further
vascular function testing was repeated at 15, 30 and 45 minutes of
recovery (i.e. POST15, POST30, POST45). An identical timeline
was replicated at the subsequent 2 visits.
Vascular Endothelial Function Testing Procedures
Comprehensive assessment of brachial vascular function was
conducted according to previous work in this laboratory using
semi-automated edge detection for diameter analysis and fast
Fourier transform of raw audio data to determine mean blood
velocity [16]. Briefly, a blood pressure cuff was placed around the
forearm aligned with the medial epicondyle at all testing sessions
and at all time points during the experimental sessions. Arterial
shear rates and blood flow were monitored using a 7 Mhz linear
array Doppler ultrasound in duplex mode (Aspen, Acuson,
Siemens Medical, Camberley, UK). Arterial diameters were
acquired for 20 heart cycles in the basal state prior to each 5
minute occlusion period and for 210 heart cycles from 30s prior to,
until ,180s post cuff deflation. All participants had resting heart
rates of below 70 bpm and all participants reached maximal
dilation within the first 90s after cuff deflation. Arterial diameters
were purposefully acquired prior to cuff deflation so that L-FMC
could be determined alongside traditional FMD parameters and
total vascular reactivity (TVR) calculated as the absolute sum of L-
FMC and FMD [16]. This procedure was repeated at 15, 30 and
45 min after the PLF. Heart rate and brachial arterial blood
pressures were also acquired at each time point.
Mean blood velocity (MBV) was determined for 30s in the basal
condition before the 5 min forearm occlusion, for 30s prior to cuff
deflation (i.e. during occlusion), and throughout reactive hyper-
aemia for 60s following cuff deflation. Shear rates were calculated
(86MBV/arterial diameter at the measurement time) and the area
under the shear rate curve was determined for 60s (AUCshear60s),
while the peak blood flow after cuff deflation was also determined
(peak MBV6pr2, where r is the diameter immediately after cuff
deflation). Finally, retrograde and anterograde area under the
MBV curves for 30s in both basal and occlusive conditions at each
time point within a session were calculated. These waere used to
determine changes in arterial shear patterns from basal conditions
prior to cuff inflation, compared to conditions of distal arterial
occlusion.
Prolonged Low Flow and Endothelial Function
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After completion of the protocol, an antecubital venous blood
sample was collected, centrifuged, and the plasma was stored in
a freezer at 280uC until analysis. Determination of serum 17-
b estradiol (Estradiol EIA kit, Cayman Chemical Item number
582251, Cambridge, UK) involved standard ELISA while pro-
gesterone was determined by competitive immunoassay and
measured directly by chemilminescent methods using an ADVIA
Centaur Progesterone Assay (Bayer). Measurements were per-
formed in the Pathology Research and Development lab of Leeds
Medical Trust, Leeds, West Yorkshire.
Statistical Analyses
Data were assessed for normal distribution using Kolmogorov-
Smirnov test. Absolute and relative FMD, absolute and relative L-
FMC, TVR, peak blood flow, 60s shear rate AUC, basal and
occlusive shear, and basal and occlusive anterograde and
retrograde 30s MBV AUC were analyzed by 2 way-repeated
measures ANOVA with ‘‘menstrual phase’’ and ‘‘time’’ treated as
within subject variables. When a significant effect was noted
Bonferroni corrected t-tests were used to determine specific
differences. Significance for all analyses was accepted as p#0.05.
All values are presented as mean 6 standard deviation. Analyses
were performed using statistical software (SPSS Version 18.0, IBM
Corporation, Somers, NY, USA). The day-to-day repeatability
(CV) for FMD, L-FMC, and TVR is 15%, 20%, and 12% (n= 8),
respectively. The absolute day-to-day difference is 1.1%, 1.4%,
and 1.7%, respectively in this laboratory by MR who conducted
all the testing sessions. Power calculation based on previous work
in this laboratory suggested a sample size of 6 participants would
be required to see a 1% change in FMD with a standard deviation
of the sample of 2% (effect size of 0.71) with a probability of 0.05
and a beta of 0.80. Thus adequate statistical power was aided by
using a sample of 8 in the present study.
Results
Participants were studied at 3 distinct points in the menstrual
cycle (17-b estradiol: Follicular: 147642 pg/ml Ovulation:
217632 pg/ml Luteal: 165635 pg/ml, progesterone: Follicular:
2.360.8 nmol/L Ovulation: 4.062.1 nmol/L Luteal:
16.864.3 nmol/L). A mean reduction in relative FMD (36%,
p,0.05) at 15 minutes post PLF was observed in these women that
was not influenced by menstrual cycle phase (Fig. 2a). Values
POST30 and POST45 after PLF did not significantly differ from
PRE. The pattern of recovery was not influenced by menstrual
phase (p.0.05). Basal diameters at each time-point were also
similar (Fig. 2b) and as a result, peak diameters and absolute FMD
were reduced following PLF at POST15 (Fig. 2c,d). Finally, time
to peak dilation showed a similar pattern with a reduction at
POST15 and a return to values not different from PRE at
POST30 and POST45. There was no impact of the menstrual
cycle phase on this value (p.0.05).
L-FMC displayed a similar pattern following PLF to FMD
alterations with a more pronounced constriction at POST15,
149% of PRE values (p,0.05) that was not influenced by
menstrual cycle phase (Fig. 2e). The absolute L-FMC change
from PRE to POST15 was 0.06 mm, while the absolute change in
FMD was 0.09 mm. As a result, there were no alterations in TVR
(Fig. 2f) after PLF although a trend for reduced TVR was apparent
at POST45 but this did not reach statistical significance (p = 0.10).
Shear Rates upon Cuff Deflation
The area under the shear rate curve (AUCshear60s), determined
over the first 60s after cuff deflation during each vascular function
measurement (i.e. PRE, POST15, POST30 and POST45), was
unaffected by menstrual cycle phase; however at all time points
after PLF, there was a reduction of between 15–22% (p,0.05)
compared with PRE. This would suggest a reduced shear stimulus
(see Fig. 3a,b) and possibly endothelial dysfunction at the level of
the resistance vessels following PLF. Peak blood flow upon cuff
release (peak reactive hyperaemia) was reduced at POST45
compared to PRE, however menstrual cycle phase had no impact
(Fig. 3c).
Basal and Occlusive Mean Blood Velocity
Mean blood velocities monitored prior to each cuff inflation
(basal) and 30s prior to cuff deflation (occlusive) during the
vascular function tests (i.e. FMD and L-FMC assessments) were
not different when they were compared between time points (i.e.
PRE vs. Post 15 etc; Fig. 4a,b). Mean blood velocities were
reduced when the forearm cuff was inflated during each vascular
function test, but the magnitude of this reduction was similar at all
time points (Fig. 4c, p.0.05). Similar to all other parameters there
was no effect of menstrual cycle phase.
Anterograde and Retrograde Shear Induced by Occlusion
The area under the anterograde and retrograde shear rate
curves were determined over a 30s period prior to each cuff
inflation (basal) and deflation (occlusive) during the vascular
function assessments (FMD and L-FMC measures). There was
a significant increase in retrograde AUC shear rate in the basal
Figure 1. Schematic representation of a testing session timeline. Participants arrived at the laboratory and rested supine for 20 minutes prior
to a brachial artery vascular function assessment (VF test). A ten-minute recovery period was immediately followed by prolonged low flow (PLF
20 min) and subsequent VF tests were completed at 15, 30 and 45 minutes into recovery. A venous blood sample was obtained at 120minutes (Q).
The VF test mean blood velocity (MBV) measurements are highlighted in the expansion. Basal MBV was measured prior to cuff inflation; occlusive
MBV 30s prior to cuff deflation; and hyperaemic MBV was measured continuously for 90s after cuff release as illustrated.
doi:10.1371/journal.pone.0055385.g001
Prolonged Low Flow and Endothelial Function
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state (p=0.02, Fig. 5c) suggesting more retrograde flow after PLF
compared to PRE. However, post hoc analyses revealed only
a tendency for higher retrograde flows at POST15 compared to
PRE (p=0.06). Anterograde AUC shear rate in the basal
condition before the vascular function assessment was unaltered
by PLF (p.0.05).
During each 5 min cuff occlusion, there was a consistent
increase in retrograde AUC shear rate (p,0.05) compared to basal
levels (Fig. 5c). Concurrently, anterograde AUC shear rate was
significantly reduced at each vascular assessment when there was
distal occlusion and this was not altered by PLF (Fig. 5b).
Discussion
The most important findings of this study were that menstrual
cycle phase had no impact on the magnitude or time course of
vascular recovery following a period of prolonged arterial low flow
induced proximal arterial injury and distal microvascular I/R
injury. We have also shown that this manipulation cannot simply
be described by alterations in FMD, since the observed reduction
in FMD coincided with a concomitant increase in L-FMC. We
observed a pronounced reduction in arterial area under the shear
rate curve induced by 5 minutes of arterial occlusion after PLF
that was not related to the peak of the hyperaemic response, but
was likely a function of the kinetics of this response (i.e. the AUC
for the hyperaemia). Finally, TVR was not altered following PLF
Figure 2. Vascular function alterations. a) Relative flow mediated dilation (FMD) was reduced after low flow induced vascular dysfunction (PLF)
(shaded area) and remained suppressed throughout recovery although it was not different from PRE at 30 and 45 minutes. b) Diameter prior to each
vascular function test was unchanged compared with PRE while c) maximal diameter was blunted and as a result d) absolute FMD was reduced at 15
minutes after PLF. e) Conversely L-FMC was augmented at 15 minutes after PLF but recovered by 30 minutes. f) As a result of augmented L-FMC and
reduced FMD, TVR was unaltered throughout the protocol. No significant differences were noted within the menstrual cycle. * Indicates a significant
main effect for time (p#0.05) from specifically difference compared to PRE PLF (post hoc comparison). FMD is flow-mediated dilation, L-FMC is low
flow mediated constriction, and TVR is total vascular reactivity.
doi:10.1371/journal.pone.0055385.g002
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suggesting an alteration in the vasodilation to vasoconstriction
relationship that was not influenced by oestrogen availability.
There are several important implications of this study. First,
naturally occurring menstrual cycle alterations in an endogenous
eNOS activator, namely 17-b estradiol, has no apparent impact at
physiological levels on recovery from PLF, and suggests the
downstream effects of oestrogen related alterations in NO are
negated by low flow and the subsequent oxidative stress induced
by reactive hyperaemia. Second, L-FMC may provide additional
information about altered vascular function and may indicate an
alteration in basal endothelial contribution to vasomotor function
before and after PLF [17]. For instance enhanced L-FMC may
indicate that any alterations in FMD might not be due to reduced
vascular function, but greater vessel relaxation after the PLF thus
blunting apparent FMD responses. Alternatively, enhanced L-
FMC may be an additional manifestation of endothelial dysfunc-
tion as suggested by Weissgerber et al. [18].
Low Flow Induced Vascular Function Changes
Previous work has established that the I/R model alters
pharmacologically induced resistance vessel endothelial dependent
vascular function [1,5,9,19] and that endothelial independent
vascular function is unaltered [3]. In addition, the endothelial
dysfunction induced by I/R is attenuated by ischemic precondi-
tioning either in the limb exposed to I/R [4] or at another site [3],
ischemic post-conditioning [2], and interventions that alter KATP
channel function [5]. Acute intra-arterial antioxidant administra-
tion also attenuates this injury [1]. Similar mechanisms may be
involved in endothelial dysfunction induced by PLF.
The reductions in FMD after PLF in the present study may
result from mechanisms related to NO bioavailability in the
brachial arterial segment. Alternatively, the reduced FMD could
be a function of the observed reduction in shear after cuff deflation
if one ascribes to the theory of shear dependent dilatory responses
in the forearm [20], although this has been challenged [21]. The
attenuated reactive hyperaemia in the current study, both
measured as the area under the shear rate curve and peak blood
flow, likely indicate microvascular endothelial dysfunction ex-
plained by a mechanism related to the opening of the mitochon-
drial permeability transition pore resulting in inadequate ATP
production and subsequent apoptotic signaling by cytochrome c in
endothelial cells [3,5]. Also, augmented reactive oxygen species
production and reduced NO bioavailability, and/or resistance
vessel obstruction by activated neutrophils [4] and/or a more
thrombogenic environment [19] could contribute to this reduced
shear stimulus.
Alteration of Flow Pattern May Alter FMD and L-FMC
Responses
Measurement of L-FMC is a unique aspect of the current study
since this measure provides additional insight about the endothe-
lial contribution to vasomotor function in basal conditions. As well,
changes in L-FMC are suggested to be mediated through
mechanisms independent of NO such as endothelin-1 [14],
cyclooxygenase products, and endothelial hyperpolarizing factor
(EDHF) [15] providing further insight into vascular function. Our
results suggest that one or more of these pathways were altered
after PLF and reperfusion, potentially due to the prolonged
increase in retrograde flow induced by distal arterial occlusion. It is
also possible, that retrograde flow induced NADPH oxidase
activation and greater reactive oxygen species production, which
would directly impact vasoconstriction. NADPH oxidase has been
suggested as the site of reactive oxygen species production with I/
R and a similar mechanism may be involved in the PLF model
[22]. Thijssen et al. (2009), using varying levels of venous
congestion, also elegantly demonstrated how altering retrograde
Figure 3. Shear rate responses after cuff deflation. a) 60s brachial
artery reactive hypaeremic shear rate area under the curve (AUC) were
reduced throughout the recovery period compared with measures
taken prior to the prolonged low flow (PLF) (shaded area). b) Peak
reactive hyperaemic blood flow was unaltered by PLF whereas c) time
to peak dilation was reduced at 15 minutes of recovery but recovered
by 30 minutes. There were no significant differences within the
menstrual cycle. * Indicates a significant difference (p#0.05) from PRE
PLF (main effect for Time) determined by post hoc analysis. AUC is the
area under the curve.
doi:10.1371/journal.pone.0055385.g003
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flow reduced FMD responses but they did not evaluate L-FMC
and our data demonstrate for the first time that vasoconstrictor
function is also altered by prolonged low flow.
Total Vessel Reactivity is Maintained
TVR is another method of evaluating the magnitude of vascular
function by assessing the combined L-FMC and FMD as a single
value [17]. This measure was unaltered by PLF but was a function,
as described, of reduced FMD and augmented L-FMC. Since
basal diameter was unchanged, an alteration in basal vessel tone is
less likely. The more likely explanation is that the altered vessel
milieu caused by oxidative stress and altered endogenous
vasoactive substances blunted FMD but conversely augmented
L-FMC.
Relation to the Forearm Ischemic-reperfusion Injury
Model
The distinct advantage of the distal cuff placement is two-fold,
but mechanistically the result of the PLF may differ from protocols
involving upper arm occlusion. One advantage of the cuff
Figure 4. Basal and distal occlusive brachial artery shear. a–b) basal brachial mean blood velocity and brachial mean blood velocity measured
when distal occlusion was applied was not altered by prolonged low flow (shaded area). c) Change in mean blood velocity upon cuff inflation was
unaltered. MBV is the mean blood velocity.
doi:10.1371/journal.pone.0055385.g004
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placement distal to the site of measurement is that it enables
continuous visualization of the vessel being investigated. In the
present study, the probe remained in place throughout the 2-hour
protocol, which ensured precise interrogation of the same portion
of the artery and enhanced reproducibility of measures. Second,
we were able to determine not only FMD responses but also L-
FMC and TVR, which would otherwise be impossible with upper
arm occlusion.
Our data suggest that measurements made proximal to the
occlusion site reflect a reduced arterial shear stimulus upon cuff
deflation, altered shear profiles and greater oscillatory shear that
contribute to reduced endothelial dependent dilation and
enhanced constriction in the conduit artery. As well, these data
suggest that the vessels proximal to the occlusion are also
detrimentally impacted and may require further study.
Figure 5. Basal and distal occlusive brachial anterograde and retrograde shear rates. a) An increase in retrograde and a concomitant
decrease in anterograde shear rate were evident upon distal arterial occlusion. This graph illustrates the mean of all vascular function responses. b)
Basal and occlusive anterograde AUC shear was not altered by the prolonged low flow (PLF) (PRE vs. POST15, 30 or 45). Similarly c) basal and
occlusive retrograde AUC shear were not altered by the PLF. Since menstrual cycle phase had no impact, mean responses are illustrated in graphs
a and b. * Indicates a significant difference (p#0.05) between basal and occlusive velocities. AUC is the area under the curve.
doi:10.1371/journal.pone.0055385.g005
Prolonged Low Flow and Endothelial Function
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Limitations
As outlined, this study involved a cohort of female participants,
which detracts from the extrapolation of the findings to male
cohorts. Blockade studies to determine the underlying mechanism
responsible for the alterations in L-FMC would be appropriate.
The sample size may limit extrapolation of the findings, however
adequate power was maintained as our results illustrate large effect
sizes congruent with our a priori sample size calculations. Finally,
the impact of repeated vascular function tests has not been
established regarding the measurement of L-FMC, however
logically if there was an impact of this simple manipulation alone,
there would not have been a return to baseline values during
recovery from the PLF. As such, we are confident that the greater
L-FMC after PLF was a result of the manipulation and not the
repeated vascular function tests. We did not assess endothelial
independent dilation to confirm previous findings and extend
them to the female cohort in this study. Further work to confirm
that the menstrual cycle does not impact the response of
endothelial independent dilation before and after a PLF stimulus
is required.
Perspectives
This study suggests that PLF augments vasoconstrictor function
of arteries proximal to a site of arterial occlusion. Blunted
endothelial dependent vessel dilation after PLF may be a function
of not only reduced arterial shear induced by reactive hyperaemia,
but also by the hemodynamic alterations upstream of the
occlusion. Specifically, reduced arterial anterograde shear and
increased retrograde shear may be responsible for the endothelial
dysfunction. Combined, the results suggest that this PLF model is
complex and warrants further investigation into the mechanisms
underlying this reaction of the conduit and microvascular
circulation.
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